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Abstract
Objective: Periodontitis is associated with cardiovascular diseases (CVD). In our previous studies a prothrombotic
state has been observed in periodontitis, which contributes to the risk of CVD. The aim of this study was to
investigate whether serum IgG levels against Aggregatibacter actinomycetemcomitans (Aa) and Porphyromonas
gingivalis (Pg) in periodontitis were associated with a prothrombotic state.
Materials and methods: Patients with moderate (n = 38) and severe periodontitis (n = 30) and controls (n = 24)
were recruited. We explored correlations between serum anti-Aa and anti-Pg IgG and plasma levels of markers of
prothrombotic state (von Willebrand Factor [vWF], prothrombin fragment 1+2 [F1+2], plasminogen activator
inhibitor-1 [PAI-1] and D-dimer). Multivariate analyses were performed considering several major potential
contributing factors.
Results: Periodontitis patients showed higher anti-Aa IgG (p = 0.015) than controls but not for Pg (p = 0.320). In
periodontitis patients, body mass index and anti-Aa IgG showed a positive correlation with vWF (b = 0.297, p =
0.010 and b = 0.248, p = 0.033 respectively).
Conclusions: In periodontitis, infection with Aa together with other well accepted risk factors for CVD, may play a
role in increasing the risk for prothrombotic state.
Introduction
Periodontitis is a chronic infectious disease of the sup-
porting tissues of the teeth and it has been consistently
associated with cardiovascular diseases (CVD) [1,2]. One
explanation in this association is that periodontitis may
also cause a prothrombotic state [3-7]. The prothrombo-
tic state is a propensity of blood to coagulate due to an
abnormality in the coagulation and/or fibrinolysis sys-
tem. In our previous study we measured well established
markers of a prothrombotic state which are risk indica-
tors for vascular ischemic events. Prothrombin factor
1+2 (F1+2) is a peptide released during the conversion
of prothrombin into thrombin, which is the final step of
the coagulation cascade (extrinsic pathway). Von Willeb-
rand Factor (vWF) is expressed by endothelial cells after
tissue damage and it triggers aggregation of platelets.
Furthermore, vWF is involved in coagulation since it
carries the factor VII of the coagulation cascade. Plasmi-
nogen activator inhibitor-1 (PAI-1) is an important inhi-
bitor of fibrinolysis and D-dimer is a polymer released
during the dissolution of the fibrin clot during fibrinoly-
sis. In our previous study we observed elevated plasma
levels of PAI-1 and vWF in periodontitis patients [3].
The systemic dissemination of periodontal pathogens
from periodontal lesions seems to be at least one cause
for the systemic inflammation in periodontitis and eleva-
tion of CVD risk markers. The periodontal pathogens
Aggregatibacter actinomycetemcomitans (Aa) and Por-
phyromonas gingivalis (Pg) have been shown in blood
and biopsies from atherosclerotic plaques [8-10]. IgG
and IgA levels against Aa and Pg have been associated
with increased risk of stroke, myocardial infarction and
increased carotid artery intima-media thickness as indi-
cation for subclinical atherosclerosis [11-14]. Further-
more an in vitro study showed that infection with Pg
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activity of PAI-1. Moreover in a meta-analysis, it was
concluded that periodontal disease characterized by ele-
vated markers of bacterial systemic exposure is asso-
ciated with CVD with a stronger association than
clinical parameters of periodontitis [15].
In light of these latter observations, we used in the
present pilot study our previous study population and
explored whether the association found between period-
ontitis and a prothrombotic state could be in part
explained by the host response to two specific periodon-
tal pathogens. Therefore the aim of this study is to
investigate whether in periodontitis serum IgG levels
against Aa and Pg are associated with systemic levels of
four markers of a prothrombotic state.
Materials and methods
Study population
The study population is retrieved from a previous study
[3]. On the basis of an extensive medical history by a
written questionnaire and by interview, the following
subjects were not included in the study: pregnant women
and individuals who suffered from any given disease or
chronic medical condition, apart from periodontitis, or
had trauma or tooth extractions in the last two weeks, or
received antibiotics within the last 3 months. We
included all subjects where serum samples were available
to determine levels of IgG against Aa and Pg. Absence of
serum sample for several subjects (n = 38) was related to
exhaustion of samples in the previous study. All details
about recruitment, definition of background variables
and approval of Medical Ethical committee are described
before. In brief, definition of a periodontal case or a con-
trol was based on the 5
th workshop guidelines [16], with
the modification that for a case > 3 mm proximal bone
loss in at least 2 non adjacent teeth needed to be present
and for a control subject the distance between the
cemento-enamel junction and the alveolar bone crest
needed to be < 3 mm on recent bitewing radiographs for
all present teeth. We used dental radiographs to estimate
the severity of periodontal destruction as described
before [17]. Patients with >7 teeth with >50% bone loss
were classified as having severe periodontitis. The
remainder of the periodontitis patients was classified as
having moderate periodontitis.
Analysis of biochemical background variables and
markers of a prothrombotic state
Systemic biochemical factors were retrieved from the
data base of our previous study [3]. Background
variables included total cholesterol, HDL and LDL
cholesterol, triglycerides and high sensitivity CRP
(hsCRP). Markers of a prothrombotic state included
vWF, prothrombin fragment F1+2, PAI-1 and D-dimer.
Analyses of serum levels of Immunoglobulin G (IgG)
against Aa and Pg
Serum levels of IgG against two relevant periodontal
pathogens, Aa and Pg, were determined by ELISA as
previously described [18], but with a modification [19].
The modification consisted of expanding the antigen
mixture, to contain all the known serotypes for Aa.
For Aa strains, ATCC 29523, Y4, NCTC 9710, 3381
and OM2 534 were used, representing respectively ser-
otypes a, b, c, d and e [20]. For Pg strains, W83, HG
184, A7A1-28, ATCC 49417, HG 1690, HG 1691 and
34-4 were used, representing respectively the capsule
serotypes K1-K7, as well as the uncapsulated strain
381(K
-) [21].
Statistical analysis
Statistical analysis of data was performed with the SPSS
package version 16.0 (SPSS, Chicago, IL, USA). Means,
standard deviations, medians, interquartile ranges and
frequency distributions were calculated for background
variables, markers of a prothrombotic state and serum
IgG’s. Normal distribution of data was assessed by
Kolmogorov-Smirnov goodness-of-fit test. Whenever
non-normal distribution was found (p < 0.05), non-
parametric tests were employed. Differences for the
background variables including markers of prothrombo-
tic state and serum IgG’s among the three groups were
analyzed by analysis of variance (ANOVA) or Kruskal-
Wallis where appropriate. A multivariate analysis
(backward stepwise linear regression with p =0 . 0 5t o
enter and p = 0.10 to leave) was performed considering
vWF, F1+2, PAI-1 and D-dimer as the outcome
variables and using as predictors periodontal status
(2 groups [moderate and severe periodontitis]), smoking,
education level, age, gender, body mass index (BMI),
total cholesterol, triglycerides, ethnicity, anti-Aa and
anti-Pg IgG levels. In the latter explorative parametric
tests, for the non-normal distributed variables, the log-
transformed values were employed. Similarly, a second-
ary explorative multivariate analysis was performed, but
now including also controls. For all analyses, p <0 . 0 5
values were considered statistically significant.
Results
Table 1 presents the background variables for the cur-
rent study population derived from Bizzarro et al.
(2007). Periodontitis patients were older than controls
(45.5 yr for the severe group, 43.8 yr for the moderate
group and 38.4 yr for controls, p = 0.017) and showed
lower educational level (p = 0.019). Periodontitis
patients had a lower number of teeth (25.7 for the
severe group and 26 for the moderate group) in com-
parison with controls (28.3, p = 0.010). Periodontitis
patients showed higher levels of PAI-1 in comparison to
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vWF and F1+2 and lower values for D-dimer, but the
differences were not statistically significant. IgG levels
against Aa were significantly higher in patients than
controls (p = 0.015). Values of IgG against Pg show a
trend for increased levels in periodontitis (Table 1).
Assuming that only in periodontitis patients an infec-
tion with Aa or Pg is causing a notable immune response,
we explored in periodontitis patients which of the back-
ground or systemic variables could be associated with
variation in the levels of the markers of a prothrombotic
state. Table 2 presents the results per marker the model
Table 1 Characteristics for the 3 study groups (control, moderate and severe periodontitis)
Control
(n = 24)
Moderate Periodontitis
(n = 38)
Severe Periodontitis
(n = 30)
p -value
1
Age (years) 38.4 ± 11.3 43.8. ± 8.7 45.5 ± 7.7 0.017
Gender NS
Male 7 (29%) 16 (42%) 13 (43%)
Female 17 (71%) 22 (58%) 17 (57%)
Ethnicity
Caucasian 21 (88%) 29 (76%) 26 (87%) NS
Other 3 (12%) 9 (24%) 4 (13%)
Education level 0.019
<High school 6 (25%) 25 (65%) 14 (47%)
=High school 7 (29%) 2 (5%) 5 (16%)
>High school 11 (46%) 11 (29%) 11 (37%)
Smoking habits NS
Smoker 7 (29%) 19 (50%) 14 (47%)
Non-smoker 17 (71%) 19 (50%) 16 (53%)
BMI (kg/m
2) 24.6 ± 3.9 26.1 ± 5.5 23.9 ± 2.7 NS
Total Cholesterol (mmol/l) 5.2 ± 1.1 5.4 ± 1.2 5.5 ± 1.1 NS
HDL/Chol. (mmol/l) 1.5 ± 0.4 1.3 ± 0.4 1.4 ± 0.4 NS
LDL/Chol. (mmol/l) 3.1 ± 1.0 3.4 ± 1.1 3.6 ± 1.0 NS
Triglycerides (mmol/l) 1.2 ± 0.6 1.5 ± 0.8 1.3 ± 0.7 NS
Total number of teeth 28.3 ± 2.3 26.0 ± 3.9 25.7 ± 3.2 0.010
Teeth ≥30% bone loss 0.0 ± 0.0 14.2 ± 5.9 21.0 ± 3.5 NT
Teeth ≥50% bone loss 0.0 ± 0.0 2.5 ± 1.6 11.0 ± 4.5 NT
hsCRP (mg/l) 1.40 (0.42-4.0) 2.18 (0.92-5.13) 1.43 (0.87-3.13) NS
Prothrombotic state
vWF (%) 75.0 (63.0-98.5) 92.5 (75.0-111.0) 90.5 (72.7-108.5) NS
F 1+2 (nmol/l) 0.84 (0.64-1.08) 1.02 (0.82-1.30) 1.01 (0.72-1.36) NS
PAI-1 (AU/ml) 0.30 (0.20-6.42) 4.32 (0.20-13.60 11.45 (1.47-27.18) 0.009
D-dimer (ng/ml) 31.0 (13.0-68.0) 25.5 (10.5-46.5) 16.0 (1.75-47.2) NS
Serum antibodies
Anti-Aa IgG 0.41 (0.36-0.63) 0.82 (0.45-1.52) 0.85 (0.39-1.58) 0.015
Anti-Pg IgG 0.60 (0.49-0.82) 0.66 (0.42-1.07) 0.70 (0.46-1.48) NS
Values are means ± standard deviations, number of subjects (%) or medians (interquartile ranges).
1 P-values obtained by analysis of variance (ANOVA), Kruskal Wallis or Chi squared test, where appropriate.
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analyses. BMI and IgG levels against Aa were signifi-
cantly associated with levels of vWF (b = 0.297, p = 0.010
and b = 0.248, p = 0.033 respectively). Female gender and
age were significantly associated with F1+2 and a trend
for an association between IgG levels against Pg and
F1+2 (b = 0.227, p = 0.058). For PAI-1, severity of period-
ontitis showed a positive correlation (b = 0.356, p =
0.001), but there was no association with IgG against Aa
and Pg. Also for D-dimer both female gender and BMI
showed positive correlations, while cholesterol showed a
negative correlation; IgG against Pg was retained in the
final model, with a negative correlation (b = -0.190), but
this association did not reach a statistical significance
(p = 0.085). When the multivariate analyses were repea-
ted including also the control subjects without periodon-
titis, we observed that the association between IgG
against Aa and levels of vWF did not reach level of signif-
icance (b = 0.181, p = 0.072), demonstrating that indeed
the exposure to a periodontal pathogen has an associa-
tion with the prothrombotic marker.
Discussion
In a previous study, our group showed that systemically
healthy periodontitis patients, in comparison to subjects
without periodontitis, displayed higher levels of 2 mar-
kers of prothrombotic state, PAI-1 and vWF [3]. Based
on these results, our aim was to investigate whether, in
the same population of periodontitis patients, IgG levels
against Aa and Pg were explanatory for these findings.
This question was raised by the evidence in the litera-
ture, which shows that levels of IgG against Aa and Pg
have been associated with CVD. In particular, a 13-year
prospective study from Pussinen et al. (2004) showed a
strong association between anti-Aa and anti-Pg IgG’sa t
baseline and the development of stroke later on.
Furthermore Aa and Pg have been found in human spe-
cimens of atherosclerotic plaques [8-10]. However, we
have no clinical evidence about the possible association
between Aa and Pg with a prothrombotic state. So far,
only in vitro or ex vivo studies are available. More speci-
fically, Aa showed to have capability to induce ex vivo
platelet aggregation in humans [5], while Pg showed
capability to induce in vitro coagulation [22] and to
enhance PAI-1 activity after in vitro infection of aortic
endothelial cells with the Pg strain 381 [23].
The main finding of the current study was that in
patients affected by periodontitis, in the multivariate
analysis levels of IgG against Aa correlated with levels
of vWF after correction and including several other
potential confounding factors. Notably, this association
was not longer significant when we included in the
study population also the controls. This strengthens
the assumption that in periodontitis patients, where the
exposure to the periodontal pathogens is stronger, infec-
tion with Aa may trigger a prothrombotic effect. In fact,
this effect seems to be diluted by adding in our multi-
variate model subjects without periodontitis and with a
relatively low response to Aa.W ec o n f i r mt h a ta l s o
BMI, age, female gender, smoking and cholesterol play
an important role [24]. Nevertheless, these results
underline a possible role of infection with periodontal
pathogens in periodontitis patients, where the immune
response to these periodontal bacteria is enhanced. vWF
plays an important role in inducing coagulation since it
is a carrier of coagulation factor VII and, when
expressed by endothelial cells, it induces platelet adhe-
sion to the endothelium. Although we cannot give a bio-
l o g i c a le x p l a n a t i o no ft h ep o s s i b l er o l eo fAa in the
mechanism that may provoke a prothrombotic state, we
may speculate that the lipopolysaccharide (LPS) pro-
duced by Aa may trigger the endothelial cells to pro-
duce more vWF [25] or, alternatively, Aa itself may
invade endothelial cells and then stimulate the release of
vWF [26].
Table 2 Multivariate analyses explored for periodontitis
patients for markers of a prothrombotic state
Subjects N = 68
Standardized b
1 p-value
1
vWF
BMI 0.297 0.010
Education - 0.198 0.086
Anti-Aa IgG 0.248 0.033
F1+2
Gender 0.258 0.029
Age 0.248 0.039
Anti-Pg IgG 0.227 0.058
PAI-1
Severity periodontitis 0.356 0.001
BMI 0.348 0.002
Age 0.283 0.008
Smoking 0.269 0.009
D-dimer
Gender 0.398 0.001
BMI 0.229 0.045
Cholesterol - 0.267 0.020
Anti-Pg IgG - 0.190 0.085
1Standardized correlation coefficient b and the p-values obtained from a
multivariate analysis (backward step-wise linear regression with p =0 . 1 0t oe n t e r
and p = 0.05 to leave) using vWF, F1+2, PAI-1, D-dimer as dependent variables
and age, gender (male = 0 and female = 1), ethnicity (not Caucasian = 0 and
Caucasian = 1), smoking status (non-smoker = 0 and smoker = 1), educational
level (3 groups), BMI, total cholesterol, triglycerides, anti-Aa IgG levels, anti-Pg IgG
levels and severity of periodontitis (2 groups, moderate and severe periodontitis)
as predictors. The retained predictors in the final models are presented.
Bizzarro et al. Thrombosis Journal 2010, 8:16
http://www.thrombosisjournal.com/content/8/1/16
Page 4 of 6In contrast with the findings of Roth et al. (2006), we
did not find a correlation between PAI-1 activity and
serum IgG against Pg. An explanation could be the fact
the Roth et al. studied selectively the production of
PAI-1 by endothelial cells in vitro; however, in vivo,
PAI-1 is produced not only by endothelial cells but also
in the liver and by adipocytes. Yet, in our multivariate
analysis we found in periodontitis patients a trend for a
positive correlation between F1+2 and IgG levels against
Pg and an inverse correlation between levels of IgG
against Pg and levels of D-dimer. F1+2 is a peptide
formed during the conversion of prothrombin into
thrombin in the coagulation cascade and D-dimer is a
marker of the turnover of fibrin dissolution in fibrinoly-
sis, the process of breakdown of the blood clot. This
might suggest that Pg m a yp l a ys o m er o l ei ne n h a n c i n g
coagulation and suppressing fibrinolysis. These sugges-
tions need to be confirmed in further research with lar-
ger populations.
There are some limitations in this study that need to
be discussed. As already mentioned, this study popula-
tion was retrieved from the population of our previous
investigation. Now we determined the IgG levels against
Aa and Pg. Unfortunately, for a number of the original
study subjects these measurements could not be per-
formed because of exhaustion of available serum. Lack
of serum for some individuals (both patients and con-
trols) led to the exclusion of these subjects and as a
consequence a reduction in the population size, in com-
parison to the original population. Another point of dis-
cussion is the lack of information about subgingival
presence of Aa and Pg in the study population. However
we consider the levels of IgG against Aa and Pg as a
reliable indicator of a possible infection with these peri-
odontal pathogens. This is currently a widely used
method in the literature [11,12,14]. Nevertheless, preli-
minary experiments on a group of 19 untreated period-
ontitis patients showed a very good correlation between
the measured levels of anti-Aa IgG and the number of
colony-forming units of Aa cultured from subgingival
flora (r = 0.800, p < 0.001). Similar results were obtained
for Pg (r = 0.650, p = 0.003).
Conclusion
In conclusion, this pilot study confirms that well
accepted risk factors for CVD correlate with markers of
prothrombotic state; these include BMI, gender, age,
smoking and cholesterol. However we also propose that
at least periodontal infection with Aa may also play an
important role, while infection with Pg is suggestive.
Further research will be necessary to confirm the findings
of the current study. In general it needs to be considered
that bacterial infection in addition to traditional para-
meters may also contribute to a prothrombotic state.
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